Podcasts about Baran

In this week's episode, I speak with Chris Baran. Chris has worn just about every hat in our profession: stylist, salon owner, podcaster, and global ambassador, but above all, he is a teacher. For nearly 60 years, he's been evolving, reinventing, and staying at the forefront of education.We talk about what it really takes to be an educator, how education has changed in the wake of the pandemic, and the role of curiosity, humility, and vulnerability in teaching.Chris shares not just technical wisdom but also the mindset shifts that make the difference between simply “instructing” and truly inspiring. Whether you're a salon owner, a stylist, or an aspiring educator, this conversation is full of nuggets about growth, leadership, and the responsibility we all have to lift others up.IN THIS EPISODE:[00:00] Introduction and welcome[00:49] Chris Baran's background and career journey[05:00] Reinvention vs. evolution in education and creativity[08:29] How do you know if you're ready to be an educator?[13:45] What makes a truly great teacher[18:00] The power of vulnerability and connection in teaching[21:00] Why “teaching what you most need to learn” matters[26:00] Validation, ego, and finding authenticity on stage[31:21] How education has changed since the pandemic[34:00] Generational shifts and the “swipe right” society[38:40] Creating a culture of growth inside your salon[46:10] Where to connect with Chris BaranWant MORE to help you GROW?

Hvordan slutter første sæson af Dark, og lever finalen op til seriens enorme mysterier og komplekse tidsrejseplot?I denne store jubilæumsepisode af Betacritic dykker Jacob Ege Hinchely og Rikke Collin ned i de to sidste afsnit af Dark sæson 1: "Alles ist jetzt" og "Alpha und Omega". Lytter, var dig: Det er stadig Spoileriffic. Serien, skabt af Baran bo Odar og Jantje Friese (1899, Who Am I), har fået massiv international anerkendelse som en af Netflix' mest ambitiøse europæiske produktioner. Finalen binder tråde sammen på tværs af tid, generationer og parallelle verdener, men rejser også nye spørgsmål, der deler både fans og anmeldere.Online har Dark's sæsonafslutning været rost for sin stemningsfulde billedside, stærke præstationer af bl.a. Louis Hofmann (Freistatt, Centre of My World) og Lisa Vicari (Luna, Isi & Ossi), samt modet til at lade mysterier stå ubesvarede. Samtidig har nogle kritikere peget på, at seriens plot bliver for komplekst og “plotdrevet” i de sidste afsnit, hvor karakterarbejdet til tider forsvinder i et virvar af tidslinjer.For Jacob og Rikke er finalen en rejse fyldt med stærke indtryk, store spørgsmål og masser af diskussioner om seriens mange mysterier. De to værter deler deres oplevelser med afslutningen på sæsonen, og Rikke har desuden en helt særlig overraskelse til lytterne i anledning af episode 50.Det er Rikkes sidste afsnit af Betacritic for nu, men hun håber at vende tilbage i fremtidige serieklubber.Tusind tak fordi du lytter med.

Çiğdem Aydoğdu'nun hazırlayıp sunduğu Turizm Gündemi programına Century21 Kurucu Baran Özbek ve Remax Master - Broker/Owner Oğuzhan Öztürk konuk oldu.

Çiğdem Aydoğdu'nun hazırlayıp sunduğu Turizm Gündemi programına Century21 Kurucu Baran Özbek ve Remax Master - Broker/Owner Oğuzhan Öztürk konuk oldu.

Okay, to review from Part 1 of this conversation, and if you didn't listen to it because you think you know how this whole skyrocketing healthcare costs thing works, let me tell you, I myself had a few revelations. So, go back and listen. For a full transcript of this episode, click here. If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe. But to be fair, if you didn't already, sure, fine. Listen to Part 2 here first and then do it backwards. It probably won't make that much difference, except you'll need to contend with me totally ruining the Part 1 suspense because here's the negative flywheel, starting with the axle. Employers and other plan sponsors have been convinced to buy discounts, including discounts or discounts by their other aliases: rebates and probably shared savings, too, I would throw in this category. This is the grease that keeps the flywheel spinning. What's the “why” there? It's a genius idea if you think about it. And if you're not fully understanding what I'm about to say, go back, for sure, and listen to Part 1 of this episode because this is a very fundamental concept that has come up over and over and over again on this podcast. Cora Opsahl (EP452) talked about it. Claire Brockbank (EP453); Eric Bricker, MD (EP472); Chris Crawford (EP465) for just four shows off the top of my head in the past, you know, eight months or so. Here's the concept: If you buy discounts, your costs will go up. Am I saying this theoretically? No, I'm not. Look at the last 20 years. Have costs gone up way higher than inflation? Yes, they have. What are we doing? We're buying discounts. So, it's hard to argue. Renewals every single year will just keep going up the longer that we buy discounts. We talk about this, Jonathan Baran and I, in Part 1, how carriers have created a really very self-serving buying framework where employers are trained to buy discounts. Discounts are the axle, and the buying of discounts becomes the top of our flywheel. And then some so inclined hospital system executives, there are certainly executives standing 10,000 feet from any bedside, so they really have zero idea how care or patients or even clinicians are impacted. But if plan sponsors buy discounts, those at health systems who are so inclined now have no real incentive to rein in prices or focus on appropriate care even. And if you are so inclined, if you're very margin focused as a healthcare executive, you know, first things first, go gut primary care. That is step one in every playbook, and we definitely talk about that in Part 1 of this episode. And also, again, in about 10 episodes from earlier this year. Another thing that you're gonna wanna do if your prime imperative is margin at a healthcare system is maximize the revenue off of every transaction. So, hey … hello, EHR systems. So now you have health system prices creeping up and up, unfettered, you know, just exacerbated by consolidation and a bunch of other different things. But you've got healthcare prices creeping up, you have volume the same or higher because we're not preventing chronic disease like you would with advanced primary care, for example. And now we're back at the “Oh wow, let me sell you another discount. And renewal is only 9% or whatever.” Thus, the flywheel spins. Alright, so let's turn this wheel around, shall we? Flip it 180. What's the fix? This is what Jonathan Baran talks about in the episode that follows, but he says, Hey, how about this? Instead of putting “get bigger discounts” in the middle of the flywheel, why don't we put “buy better member health”? That's a good start. Buy a health plan that delivers better member health at an affordable price. Buy the care, not buy a discount off of a price we can't see for net price we can't see. Is it insurance? I don't know. Right? Like, just buy the healthcare. Cutting to the chase, Jonathan Baran advocates for a paradigm shift where employers invest in primary care, adopt better benefit designs, more aligned to cost and quality so that members are incented toward better cost and quality, employee navigation services to guide employees to make more informed healthcare decisions. So again, by changing the focus from buying discounts to buying actual healthcare, Jonathan says, we can reverse the negative cycle and improve overall health outcomes. As I've said multiple times already, my guest today is Jonathan Baran. He has been, for a long time, a healthcare entrepreneur. Today he is co-founder and CEO of Self Fund Health in Wisconsin, committed to challenging the expensive healthcare system in Wisconsin. Self Fund Health, I am always so pleased to tell you, did make a really, really kind offer to help out RHV (Relentless Health Value) financially. You and the tribe here are really great folks who I truly, truly appreciate. So, please do support Self Fund Health if you are in Wisconsin. This podcast is sponsored by Self Fund Health today. Also mentioned in this episode are Self Fund Health; Cora Opsahl; Claire Brockbank; Eric Bricker, MD; Chris Crawford; Cynthia Fisher; Scott Haas; Peter Hayes; Matt McQuide; RxSaveCard; Mark Cuban; Ramy Khalil, MD; Candace Shaffer; and Tom Nash.   You can learn more at Self Fund Health and follow Jonathan on LinkedIn.   Jonathan Baran is a serial healthcare IT entrepreneur and the co-founder and CEO of Self Fund Health, a fast-growing health plan redefining how employers buy and manage healthcare. With a mission to eliminate waste and realign incentives in the healthcare system, Self Fund Health empowers employers to take control of rising costs by giving employees access to high-value providers at no cost, while replacing traditional insurance with real-time technology, dedicated nurses, and an aligned ecosystem of care. Prior to founding Self Fund Health, Jonathan was the co-founder and CEO of Healthfinch, one of the pioneering companies to build apps on top of electronic medical records. Healthfinch automated routine workflows for physicians using clinical data, significantly improving efficiency and patient care. Under Jonathan's leadership, Healthfinch raised over $15 million in venture capital and scaled to more than 50 employees. The company received national recognition, including being named a “Cool Vendor” by Gartner, a “Top Emerging Vendor” by KLAS, and one of Modern Healthcare's “Best Places to Work.” In 2020, Healthfinch was acquired by HealthCatalyst. Jonathan holds both a bachelor's and master's degree in biomedical engineering from the University of Wisconsin–Madison. He lives in Madison, Wisconsin, and continues to push the boundaries of innovation in employer-sponsored healthcare.   05:23 Where to start in reversing the flywheel. 06:57 Why investing in primary care is pivotal to containing healthcare costs. 10:02 EP453 with Claire Brockbank. 10:04 EP452 with Cora Opsahl. 10:07 EP457 with Cynthia Fisher. 10:12 EP365 with Scott Haas. 10:13 EP465 with Chris Crawford. 10:14 EP475 with Peter Hayes. 11:11 EP468 with Matt McQuide. 11:13 EP472 with Eric Bricker, MD. 12:14 “The most expensive thing in healthcare is the pen of the primary care doctor.” 13:04 How the role of the broker has to fundamentally change. 16:16 What will the single most challenging aspect of this restructuring become? 20:20 How self-funded employers can be amazing customers in containing the rising cost flywheel in healthcare. 22:56 How do EHRs and other medical record systems play into reversing the flywheel of rising healthcare costs? 23:57 Ramy Khalil, MD's post on interoperability. 24:59 Why is it important for employers to drive volume differently? 25:38 How Self Fund Health is helping in this regard.   You can learn more at Self Fund Health and follow Jonathan on LinkedIn.   @JonathanBaran discusses how to contain increasing #healthcarecosts on our #healthcarepodcast. #healthcare #podcast #financialhealth #patientoutcomes #primarycare #digitalhealth #healthcareleadership #healthcaretransformation #healthcareinnovation Recent past interviews: Click a guest's name for their latest RHV episode! Jonathan Baran (Part 1), Jonathan Baran (Bonus Episode), Dr Stan Schwartz (Summer Shorts), Preston Alexander, Dr Tom X Lee (Take Two: EP445), Dr Tom X Lee (Bonus Episode), Dr Benjamin Schwartz, Dr John Lee (Take Two: EP438), Kimberly Carleson, Ann Lewandowski (Summer Shorts), Andreas Mang and Jon Camire (EP479), Justin Leader (Take Two: EP433)  

In this bonus clip from Episode 483 of Relentless Health Value, host Stacey Richter discusses the efforts of individuals working within large healthcare organizations to improve patient outcomes despite systemic challenges.  Guest Jonathan Baran, co-founder and CEO of Self Fund Health, highlights how incentives within the healthcare system drive behaviors that often conflict with patient and member interests.  The discussion emphasizes the importance of not generalizing the intentions of all employees based on organizational actions and encourages a deeper understanding of underlying incentive structures to foster meaningful changes.  Self Fund Health, I am so pleased to tell you, as I am always so pleased to tell you, did make such a kind offer to help out Relentless Health Value financially. You and the tribe here are really, really great folks who I truly appreciate. Please support Self Fund Health if you are in Wisconsin. This episode is sponsored by Self Fund Health. === LINKS ===

In this episode Stacey Richter speaks with Jonathan Baran, CEO of Self Fund Health in a detailed exploration of what they term the 'Flywheel Downward Spiral' of American healthcare costs. The conversation delves into how electronic health records (EHR) and the incentives driving insurers, brokers, and hospital systems contribute to consistently rising healthcare premiums.  Key points include how insurers profit from high premiums, the misleading marketing focus on discounts rather than actual costs, and the role of EHR systems in maximizing hospital profits rather than improving patient care. The episode sets the stage for a subsequent discussion on reversing these trends, aiming to align healthcare outcomes with cost reductions. Self Fund Health, I am so pleased to tell you, as I am always so pleased to tell you, did make such a kind offer to help out Relentless Health Value financially. You and the tribe here are really, really great folks who I truly appreciate. Please support Self Fund Health if you are in Wisconsin. This episode is sponsored by Self Fund Health. === LINKS ===

Hosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, Kentaro Ejiri, MD, and Satoshi Shoji, MD, welcome Dr. Kunihiro Matsushita of Johns Hopkins University to discuss findings from the ARIC study on cumulative cardiovascular risk and healthy arterial aging. Dr. Matsushita highlights that maintaining favorable levels of cholesterol, blood pressure, and avoiding smoking from mid- to late-life is strongly associated with the absence of coronary artery calcium (CAC) at older age—a marker of healthy arterial aging. The study emphasizes the long-term impact of sustained risk factor control and its implications for preventive cardiology and public health.

Hosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, and Nobuhiro Ikemura, MD, welcome Yuichi Saito, MD, of Chiba University Hospital, to discuss recent trends in out-of-hospital cardiac arrest (OHCA) among Japan's oldest populations. Using data from the All-Japan Utstein Registry, Dr. Saito and the Japanese Circulation Society Resuscitation Science Study (JCS-ReSS) Group highlight that OHCA cases in nonagenarians are steadily increasing. Despite prehospital resuscitation efforts, outcomes—particularly neurologically favorable survival—remain poor in this age group. The study underscores the urgent need for a national conversation on resuscitation strategies in a super-aging society.

Hvordan endte vi her - og hvornår er “her” egentlig?I denne spoileriffic episode af Betacritic dykker Jacob Ege Hinchely og Rikke Collin videre ned i Netflix-serien Dark (skabt af Baran bo Odar og Jantje Friese, også kendt for 1899 og Who Am I) og diskuterer afsnit 5 og 6 af første sæson - to episoder, hvor mysteriet for alvor tager fart, og tidsrejsetrådene begynder at spinde sig tættere og tættere sammen.Afsnittene - “Wahrheiten” og “Sic Mundus Creatus Est” - blev begge rost internationalt ved seriens premiere for deres komplekse opbygning, stilistiske præcision og unikke tilgang til sci-fi-genren. Kritikerne fremhævede særligt, hvordan serien balancerer filosofiske spørgsmål med spænding og psykologisk drama, hvilket netop træder frem i disse midterafsnit.Jacob er for alvor blevet fanget af mysteriet og sammenligner seriens struktur med en tysk julekalender, hvor hvert afsnit afslører nye brikker i et langt større puslespil. Rikke bliver dybt rørt og kalder afsnittene nogle af de mest bevægende i serien - med både følelsesmæssig dybde og tankevækkende afsløringer.Tidsrejser, familiehemmeligheder, et uopklaret lig og en kædereaktion af begivenheder fra både 1953, 1986 og 2019 smelter sammen i to episoder, der i den grad har sat Dark på verdenskortet som en af de mest ambitiøse sci-fi-serier i nyere tid.Serieklubben vender tilbage om fire uger med mere Dark.Billetter til Betacritic: Det store Dellemisshow er nu til salg!Jacob og Rikke optræder live på Hotel Cecil i København den 29. september.Køb dine billetter her: https://www.hotelcecil.dk/datoer/betacriticTusind tak fordi du lytter med.

Après 20 ans dans une prison indonésienne, Serge Atlaoui est de retour en France. Mais dans quelles conditions psychologiques est-il ? Peut-il reprendre une vie normale ? Quels sont ses traumatismes ? Écoutez Marilyne Baranès, expert judiciaire spécialiste du traumatisme. Ecoutez L'invité événement avec Agnès Bonfillon du 18 juillet 2025.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Après 20 ans dans une prison indonésienne, Serge Atlaoui est de retour en France. Mais dans quelles conditions psychologiques est-il ? Peut-il reprendre une vie normale ? Quels sont ses traumatismes ? Écoutez Marilyne Baranès, expert judiciaire spécialiste du traumatisme. Ecoutez L'invité événement avec Agnès Bonfillon du 18 juillet 2025.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Er Dark den mest ambitiøse mysterieserie i nyere tid?Efter afslutningen på The Last of Us sæson 2 vendte Jacob Ege Hinchely og Rikke Collin sig mod Dark, den tyske sci-fi-thriller skabt af Baran bo Odar og Jantje Friese (også kendt for 1899), som straks fangede deres interesse. I denne episode gennemgår de tredje og fjerde afsnit, også kendt under titlerne "Gestern und Heute" og "Doppelleben", og ser nærmere på Winden-universets øgede kompleksitet.Serien følger op på mysteriet om forsvundne børn og komplekse familieforhold i den fiktive tyske by Winden, med en sammenflettet rollebesætning: Louis Hofmann (Land of Mine, The Forger) som Jonas Kahnwald og Oliver Masucci (Fantastic Beasts: The Secrets of Dumbledore, Look Who's Back) som Ulrich Nielsen. Dark's visuelle stil, brug af musik – herunder Apparat, Agnes Obel og Fever Ray – samt filosofiske temaer og 33-års-cyklen har gjort serien til et globalt fænomen og et benchmark for ikke-engelsksprogede produktioner.Online er serien hyldet for sin struktur, hvor hver detalje har betydning, og hvor genlæsninger og fan-teorier florerer på Reddit, IMDb og dedikerede platforme som https://dark.netflix.io/. Den tilhører genren “mystery box”-underholdning – og hver nye karakter og historienetværk kræver fuld opmærksomhed.Tusind tak fordi du lytter med.

Alicja Baran ma 19 lat i właśnie spędza swoje pierwsze wakacje nad polskim morzem. W połowie pobytu musi przerwać swój wyjazd na kilka dni, ale postanawia wrócić… jednak nigdy już nie dociera do celu. Z kodem promocyjnym 40HERRING uzyskacie 40% zniżki na pierwsze DWA zamówienia PsiBufet! Zamów tutaj: ⁠https://psibufet.pl/40herring

COACH CHRIS is in the house!!! I'm so honored to have Chris Baran share his origin story, his struggles, his success and, of course, his advice to all of us in the professional beauty and barber industry. As an award-winning hairstylist and educator, Chris laid it all out during this chat and you are sure to love and learn what he has to say as a hairstylist, owner and barber in the industry today. Check it out and leave your feedback in the comments or as a spotify/apple review! WANT MORE CHRIS?Website: https://chrisbaran.com/Education: https://trainersplaybook.com/nstagram: https://www.instagram.com/coachchrisbaran/?hl=enWANT MORE KRYSTINE?For 1:1 Coaching, Freebies & More, TAP HERE: bit.ly/3S5R2loLOVE THIS EPISODE?Leave Your Ratings, Reviews & Comments on the Podcast! Your feedback allows for more nourishing content and for more on-point education for beauty & barber pros.

What if you could close the gap between what you think your customers experience and what they actually feel—using raw, unfiltered feedback you can see and hear for yourself? In a constantly evolving digital landscape, the journey from a customer's very first click to their final interaction is more complex—and crucial—than ever before. But many leaders believe that their customer experience is far better than it really is—a costly blind spot that leads to missed opportunities for building trust and loyalty. How can organizations truly see their products and services through their customers' eyes and outpace the competition in building brand confidence? You won't want to miss this week's Delighted Customers Podcast, where Mark Slatin sits down with Baran Erkel, Chief Strategy Officer at User Testing. Baran's rich background—from developer to consulting to enterprise SaaS leadership—gives him a unique 360-degree view on why empathy at scale is the new differentiator and how User Testing's platform enables businesses to bring the authentic voice of the customer into every decision. If you're a leader who wants to turn insight into action, streamline feedback loops, and future-proof experiences in the age of AI, Baran's expertise is essential listening. Here are three compelling questions Baran Erkel answers on this episode: Why is traditional customer feedback (like NPS surveys) not enough for truly understanding and closing the customer experience gap? How does User Testing enable organizations to “get out of the building” and immerse themselves in real-time, video-based customer feedback—even at scale? What is the transformative role of AI in the future of human insights, feedback, and designing for trust? Tune in to this insightful conversation and discover how to proactively bridge blind spots in your customer journey. Listen and subscribe on Apple Podcasts and Spotify—or catch Delighted Customers on all of your favorite podcast platforms so you never miss an episode! Meet Baran Erkel Baran Erkel is the Chief Strategy Officer at User Testing, where he leads strategy, corporate development (including mergers and acquisitions), and product management for their industry-leading platform. With over 15 years in enterprise software and a career foundation in computer science and consulting, Baran's passion lies in helping businesses harness human insights to drive innovation and deepen customer trust. User Testing, founded in 2008, now serves over 3,000 clients—including global enterprises in financial services, tech, and retail—by enabling rapid, actionable feedback through both digital and physical customer experiences. Baran is committed to equipping organizations with the tools and mindset shifts needed to close the “experience gap” and thrive in today's competitive landscape. Connect with Baran on LinkedIn. Show Note References Coupa Café anecdote illustrating the powerful impact of real-time, direct customer feedback The Bain & Company “CX Gap” statistic User Testing's role in transitioning from reactive to proactive customer listening The future of AI-powered feedback and its integration with human insights Don't forget to listen and subscribe—transform your approach to customer experience starting today!

Hosts Mitsuaki Sawano, MD, Kentaro Ejiri, MD, and Nobuhiro Ikemura, MD, welcome Yuki Obayashi, MD, of Leiden University Medical Center, to discuss findings from the STOPDAPT-3 trial. Dr. Obayashi highlights that, among ACS patients—including those with HBR or STEMI—aspirin and clopidogrel monotherapy after 1 month of DAPT resulted in similar rates of ischemic and bleeding events. These results support flexible, patient-centered antiplatelet strategies beyond the acute phase.

Is NAD the Missing Link in Longevity and Cellular Repair? In this episode of Medical Disruptors, Dr. Efrat LaMandre sits down with Baran—an entrepreneur who partnered with a Harvard-trained scientist—to uncover the truth about one of the most underrated molecules in the human body: NAD. They explore why NAD is essential for energy, focus, and DNA repair, and reveal what really causes your levels to start dropping in your 30s. That decline isn't just a number—it's directly linked to fatigue, brain fog, and the visible signs of aging. But this isn't about popping a supplement and hoping for the best. Baran breaks down why taking NAD alone isn't enough, what your body truly needs to rebuild it, and how chronic inflammation can quietly sabotage the process before your cells ever get the benefit. This episode isn't about hype or hacks—it's about strategy. Science-backed, body-aware strategy. If you're ready to protect your brain, restore your energy, and take a smarter approach to aging, this is where it starts.

In this episode, host Mitsuaki Sawano, MD, is joined by Dr. Shoichiro Yatsu, MD, to discuss his sub-analysis of the ADVENT-HF trial, recently published in JACC: Heart Failure. The study investigates the effects of peak-flow-triggered adaptive servo-ventilation (ASVPF) on left ventricular (LV) structure and function in patients with heart failure and sleep-disordered breathing (SDB). Compared to earlier studies using different ASV algorithms, ADVENT-HF highlights the safety and clinical value of ASVPF, showing meaningful improvements in sleep quality, symptoms, and quality of life. Dr. Yatsu also shares insights from managing legacy trial data collected over more than a decade.

In this episode, hosts Mitsuaki Sawano, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD, are joined by Dr. Yoichiro Sugizaki, MD, for an in-depth discussion on his landmark OCT-based study investigating chronic stent recoil (CSR) and its impact on target lesion revascularization (TLR) in the contemporary era of thin-strut, second-generation drug-eluting stents (DES). Together, they delve into the frequency, mechanisms, and clinical relevance of CSR—an underappreciated phenomenon increasingly observed in heavily calcified or eccentric lesions despite technological advancements in stent design. The conversation underscores why recognizing CSR is essential for interventional cardiologists and explores practical strategies to mitigate its impact.

Herec Kristián Baran sa do povedomia Slovákov dostal veľmi rýchlo. Dopomohla k tomu seriálová postava učiteľa telesnej výchovy a hneď na to sa ukázal aj v tanečnej show. Aj keď tvrdí, že netancoval ani na diskotékach, na televíznych obrazovkách ukázal spolu s tanečnou partnerkou Dominikou Roškovou svoje kvality a nakoniec aj vyhral.V Mimóze sa (ne)dozviete:1:00 – ako sa učil spisovnú slovenčinu;3:30 – prečo chodil po strednej škole ešte na konzervatórium;7:15 – čo mu dalo konzervatórium;9:50 – ako vyzerali jeho štátnice;11:20 – či herectvo splnilo jeho očakávania;13:30 – ako sa dostal do Divadla Petra Mankoveckého;21:15 – akou postavou z minulosti by chcel byť;24:50 – či bol pripravený na slovenský showbiznis;28:45 – ako sa cítil po prvom večery v tanečnej show.

Hosts Mitsuaki Sawano, MD, and co-hosts Kentaro Ejiri, MD, and Satoshi Shoji, MD, are joined by HFpEF expert Hidehiro Yaku, MD, from Northwestern University, for a deep dive into early treatment response to acoramidis, an amyloid stabilizer recently approved in Japan. They discuss its impact on serum transthyretin (sTTR) levels and the emerging role of sTTR as a dynamic biomarker of treatment efficacy. The episode explores the clinical relevance of early sTTR elevation, key insights from the ATTRibute-CM trial—including mediation and logistic regression analyses—and the use of waterfall plots to visualize treatment response. The team also compares acoramidis with tafamidis and vutrisiran, and looks ahead to the evolving therapeutic landscape of ATTR-CM, including gene editing and amyloid removal strategies.

Hosts Mitsuaki Sawano, MD, and Nobuhiro Ikemura, MD, welcome Yoshitaka Kimura, MD, PhD, of Leiden University Medical Center, to discuss proactive ablation strategies in patients with repaired Tetralogy of Fallot (rTOF). Dr. Kimura presents data from a long-term, single-center study evaluating electroanatomical mapping and preventive ablation of slow-conducting anatomical isthmuses (SCAI) in rTOF patients without prior ventricular tachycardia (VT). The findings show that identifying and successfully ablating SCAI significantly reduced VT incidence, with all VT events occurring in patients where ablation failed. Moreover, this approach reduced the proportion of patients qualifying for ICD implantation from 25–51% under current guidelines to just 11%. Dr. Kimura underscores a paradigm shift in congenital heart disease management—from treating VT reactively to preventing it proactively—highlighting the value of data-driven, tailored care strategies that avoid unnecessary device implantation and better target high-risk individuals.

Mark your calendar for July 11-13! If you are a hunter rider, trainer, and fan, get ready for the hunter event of the year taking place this summer in Valkenswaard, Netherlands. "The Baran" is the first of its kind Global Hunter Classic with big aspirations to grow the hunter sport. Bethany sits down with co-founder Andrew Lustig to hear all about the inaugural event. 

Hosts Mitsuaki Sawano, MD, co-host Nobuhiro Ikemura, MD, welcome Kentaro Kamiya, PhD, from Kitasato University, to discuss the ACTIVE-ADHF trial, a landmark multicenter RCT on early cardiac rehabilitation in acute decompensated heart failure. The study found that initiating exercise-based rehab during hospitalization significantly improved physical function, quality of life, and activity levels at discharge—even in non-frail patients—without increasing adverse events. Dr. Kamiya emphasizes that early rehab can prevent functional decline and support recovery, challenging assumptions about who benefits from acute-phase intervention and offering globally relevant evidence grounded in Japan's unique clinical setting.

Happy Mother's Day to all the incredible mothers around the world! In this week's episode, Colleen is joined by Baran, a Bilkent University Political Science graduate, to discuss Kurdish Cinema in the context of Voice of My Father (2012, dir. Orhan Eskiköy) and Turtles Can Fly (2004, dir. Behmen Kubadi).

You can buy solar panels in many places around the world for around 10 cents-a-watt— so why are Americans still paying an average of about $3.70 for every watt installed?In this candid and fiery live episode, Nico Johnson sits down with long-time clean energy champions Andrew Birch and Kerim Baran to unpack what's really slowing down solar deployment in the U.S. The verdict? Bureaucracy, bad trade policy, and a lack of open-market access are dragging us down.From SolarApp to tariffs to balcony solar, this conversation delivers a clear-eyed exploration of clean energy economics and the tension between innovation and regulation. Birchy argues for smarter global trade to lower prices and create more jobs—not fewer. And Kerim asks the tough questions about sovereignty, security, and system-wide inefficiencies. We've got further reading down in the resources section, but first you'll want to tune into this discussion to learn:

Hosts Mitsuaki Sawano, MD, and co-host Satoshi Shoji, MD, welcome regional associate editor Kentaro Ejiri, MD, for his debut appearance on the JACC: Baran Journal Club. Dr. Ejiri presents insights on the Altshock-2 trial, a pivotal randomized controlled trial evaluating early intra-aortic balloon pump (IABP) support in heart failure-related cardiogenic shock (HF-CS). The discussion covers the trial's clinical relevance, key challenges, and the implications of its findings within the Japanese healthcare context. The episode also delves into evolving definitions of cardiogenic shock, trial methodology, and the potential for Altshock-2 to inform more individualized treatment approaches in Japan.

Hosts Mitsuaki Sawano, MD, co-host Shun Kohsaka, MD, and Nobuhiro Ikemura, MD, welcome Tomohiko Taniguchi, MD, from Kobe City Medical Center General Hospital, to discuss findings from the CURRENT AS Registry-2 on low-gradient severe aortic stenosis (AS). Based on data from over 3,300 patients across 21 Japanese centers, the study categorized AS into four hemodynamic subtypes, revealing that low-gradient AS with reduced LVEF had the poorest prognosis, paradoxical LFLG AS was associated with high rates of atrial fibrillation and advanced cardiac damage despite low valve calcification, and normal-flow LG AS frequently exceeded guideline-based calcification thresholds despite being labeled as moderate. Dr. Taniguchi emphasizes the need to revise conventional illustrations of AS subtypes by incorporating cardiac damage and frailty and underscores the importance of proper statistical interpretation in subgroup analyses.

This episode starts with "Vatican III is for dogs," if you want to set your expectations ahead of timeThe Haint ™ is also feeling EXTRA festive, so just prepare yourselves spiritually for thatWe are minus one Ryan this week and plus one Victoria Zeller. Double celebrity author show!! Pre-order Victoria's book here, if you're a ball-knower or would like to be perceived as such: https://victoria.monster/#bookdriveCharity Bowl results are in! Y'all blew us away! You can see the results at moneycannon.org. LET US NOW SING THE PRAISES OF THE MATTIVERSEIt's NFL Draft week, apparently, so we're drafting discontinued fast food itemsThis is an exercise that seems harmless enough but results in a confession from Spencer more horrifying than any Ricky Gervais voice he's ever doneSpencer crosses the barAn unexpected wildlife encounter at Holly's place provides us with a rare unintentional cliffhangerFullcast theme song arranged and performed by Russell PowellCheck out Surber's band, Killer Antz: https://linktr.ee/killerantzSign up for update's about Ryan's secret new project at falconscottproductions.comCheck out Jason's free CFB Watch Grid newsletter and other work: https://www.jasonkirk.fyi/DID YOU KNOW: Holly and Spencer write a year-round newsletter, featuring football and also unfootball things, at https://channel-6.ghost.io/

Hosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, and Nobuhiro Ikemura, MD, welcome Masashi Amano, MD, from the National Cerebral and Cardiovascular Center in Japan, to discuss his recent article titled "Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy," published in JACC: Heart Failure.Drawing from the REVEAL-HCM registry of 3,611 patients across 21 Japanese centers, the study evaluated how well U.S. and European guidelines for ICD implantation apply to Japanese patients with HCM. The findings revealed poor outcomes in end-stage HCM (EF

Emre Baran, CEO and co-founder of Cerbos, and Alex Olivier, CPO and co-founder, join SE Radio host Priyanka Raghavan to explore “stateless decoupled authorization frameworks. The discussion begins with an introduction to key terms, including authorization, authorization models, and decoupled frameworks. They dive into the challenges of building decoupled authorization, as well as the benefits of this approach and the operational hurdles. The conversation shifts to Cerbos, an open-source policy-based access control framework, comparing it with OPA (Open Policy Agent). They also delve into Cerbos's technical workings, including specification definitions, GitOps integration, examples of usage, and deployment strategies. The episode concludes with insights into potential trends in the authorization space. This episode is sponsored by Penn Carey Law school

Hosts Mitsuaki Sawano, MD, and Nobuhiro Ikemura, MD, welcome Yuichiro Mori, MD, MPH, a physician-scientist at Kyoto University, to discuss his ACC.25 poster presentation on biomarker-based pre-heart failure screening using NT-proBNP, conducted in a rural Japanese city in Hokkaido. Drawing from a screening cohort of 1,585 individuals aged 40–74 in Furano, the study integrated NT-proBNP testing into Japan's routine general health checkups. Dr. Mori shares key takeaways from the study and emphasizes how even single-site efforts, when well-structured and strategically communicated, can gain recognition at major global meetings like ACC.

Hosts Mitsuaki Sawano, MD, and co-host Satoshi Shoji, MD, welcome Kenji Inoue, MD, to discuss the DROP-Asian ACS study—a multicenter trial evaluating the 0/1-hour algorithm for chest pain assessment across 12 hospitals in five Asian countries presented as a Late Breaking Clinical Trial at the ACC.25. Dr. Inoue shares key findings from this cluster-randomized trial of nearly 4,000 patients, highlighting the algorithm's practicality in Asia's diverse healthcare settings. Despite regional differences, the 0/1-hour approach—requiring only two high-sensitivity troponin measurements—proved effective and accessible, even in low-resource environments. He also reflects on presenting at ACC, the importance of early preparation, and the growth that comes from taking on complex international research. Dr. Inoue encourages young clinicians to embrace challenges and actively engage with global networks for clinical research development.

Four different locations for Episode 242! Jack and Baran kick off the podcast by discussing his recent retirement from MLW and his life outside the league. Then, Tom is on the road while Kyle joins in studio to break down the other off-season moves in the league! Enjoy!

Hosts Mitsuaki Sawano, MD, and Regional Associate Editor Nobuhiro Ikemura, MD, welcome Takashi Ikenouchi, MD, a physician scientist at the Cedars-Sinai Medical Center, Smidt Heart Institute, to discuss the headline-grabbing “Gold Card” sale and a novel approach to atrial fibrillation: an embryological classification of arrhythmogenic triggers. While pulmonary vein isolation (PVI) remains the cornerstone of AF ablation, up to 30% of triggers originate outside the pulmonary veins, contributing to recurrence and suboptimal outcomes. As PVI outcomes begin to plateau, this embryology-informed framework—categorizing triggers into common pulmonary vein, sinus venosus, and primitive atrium origins—offers a path toward more personalized and precise AF therapies.

Send us a textIn this episode, Ricardo Karam meets Serwan Baran, an Iraqi Kurdish artist whose life has been a series of challenges and transformations, which are reflected in his work that embodies conflict, pain, and belonging.Born in Baghdad in 1968, he developed a passion for painting from a young age, which led him to study fine arts at Babylon University, where he graduated in 1992 as the first in his class.  After graduating, he began his career as a professor at the Faculty of Fine Arts at Baghdad University for seven years, but he soon realized that teaching limited his creative energy and decided to devote himself to his art. From being arrested at the age of 16 for a political joke, to the years of economic siege in the 1990s when he earned a salary of only $4 per month, to leaving Iraq and living in Syria and Jordan before later settling outside his homeland, Baran's life has been marked by difficult experiences that have characterized his life. His work was influenced by these stages, moving from realistic painting to a more abstract style, using visual symbols that reflect violence, power, and psychological brokenness.  Join this in-depth interview with Serwan Baran, as he tells his stories of art, freedom, and exile, and talks about the challenges he has faced in his artistic and personal journey.في هذه الحلقة، يلتقي ريكاردو كرم مع سيروان باران، الفنان الكردي العراقي الذي شكّلت حياته سلسلة من التحديات والتحولات، فانعكست على أعماله التي تجسّد الصراع، الألم، والانتماء. وُلِد في بغداد عام 1968، وبرز منذ صغره بشغفه بالرسم، ما دفعه إلى دراسة الفنون الجميلة في جامعة بابل، حيث تخرّج عام 1992 كالأول على دفعته.  بعد تخرّجه، بدأ مسيرته كأستاذ في كلية الفنون الجميلة بجامعة بغداد لمدة سبع سنوات، لكنه سرعان ما أدرك أنّ التدريس يحدّ من طاقته الإبداعية، فقرر التفرغ لفنه. شارك في أكاديمية الصيف في دار الفن بعمّان عام 2000، حيث تتلمذ على يد الفنان السوري الحداثي ماروان كاسب باشي، ما كان له أثر كبير في تشكيل أسلوبه الفني.  عاش سيروان باران تجارب صعبة طبعت حياته، بدءاً من اعتقاله في سن السادسة عشرة بسبب نكتة سياسية، مروراً بسنوات الحصار الاقتصادي في التسعينيات حيث كان يتقاضى راتباً لا يتجاوز 4 دولارات شهرياً، وصولاً إلى مغادرته العراق والعيش في سوريا والأردن قبل أن يستقر لاحقًا خارج وطنه.تأثرت أعماله بهذه المحطات، فانتقل من الرسم الواقعي إلى أسلوب أكثر تجريداً، مستخدماً رموزاً بصرية تعكس العنف، السلطة، والانكسار النفسي.  انضموا إلى هذا اللقاء العميق بين ريكاردو كرم وسيروان باران، حيث يروي الأخير قصصه عن الفن، الحرية، والمنفى، ويتحدث عن التحديات التي واجهها في رحلته الفنية والشخصية.

Hosts Mitsuaki Sawano, MD, and Shun Kohsaka, MD, FACC, welcome Saki Ito, MD, a physician scientist at the Mayo Clinic, to discuss key topics expected at the upcoming ACC.25 in Chicago and a nuanced phenotype of aortic stenosis (AS): high-gradient AS with an aortic valve area (AVA) greater than 1.0 cm². Drawing from a recent retrospective study at Mayo Clinic, Dr. Ito examines the heterogeneous nature of this group—including patients with bicuspid valves and elevated stroke volume due to larger body size—and the potential prognostic benefit of aortic valve replacement (AVR) despite the absence of classic severity markers.

Hosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, FACC, and Makoto Mori, MD (Associate Editor) welcome Dr. Tsuyoshi Kaneko, MD, a cardiovascular surgeon, to discuss the impact of federal funding cuts at Columbia University and findings from a large-scale STS database study on bioprosthetic vs. mechanical aortic valve replacement (AVR) in patients aged 40-75 years. Dr. Kaneko provides a surgical perspective on risk-adjusted comparisons, data linkage challenges, and potential biases, while also sharing insights on publishing in JACC and essential writing tips for Japanese researchers.

Hosts Mitsuaki Sawano, MD, and Shun Kohsaka, MD, FACC, discuss the end of Skype and before welcoming Dr. Nobuyuki Kagiyama, MD (Juntendo University), to explore findings from the SONIC-HF Registry on the prognostic value of diaphragm ultrasound in heart failure patients. The episode covers ultrasound methodology, research challenges, and clinical implications for heart failure management.

In this week's JACC Baran (Episode 4), hosts Mitsuaki Sawano, MD, JACC Executive Associate Editor, and Shun Kohsaka, MD, FACC, JACC Regional Editor welcome Koshiro Sakai, MD, to discuss the 2025 revised ACS guidelines and Photon-Counting CT (PCD-CT). A retrospective cohort study of 7,500 cases suggested an association between PCD-CT and enhanced diagnostic accuracy, with potential implications for reducing unnecessary invasive catheterization procedures. The episode also highlights global research perspectives and the importance of clear scientific communication.

Send us a textEver wondered how your favorite Hallmark characters get their signature looks? In this exclusive interview, we go behind the scenes with Kelsey Baran, the brilliant costume designer behind Hannah Swensen Mysteries and countless other Hallmark favorites. Kelsey shares her journey into the film industry, the creative process of bringing characters to life through fashion, and the challenges of dressing stars—from casual small-town bakers to glamorous mystery-solvers.We talk wardrobe malfunctions, fashion inspirations, Easter eggs hidden in costumes, and even how Kelsey subtly evolved Hannah Swensen's style while staying true to her beloved character. Plus, she reveals the actor who was an absolute dream to work with and the costume that became an unexpected fan favorite.If you love Hallmark movies, behind-the-scenes insights, or just great storytelling through fashion, this episode is a must-listen!

This episode of JACC-Baran features a brief discussion on Kendrick Lamar and the history of racial discrimination in the United States. Then Hiroki Ueyama, MD, from Emory University discusses his study on P2Y12 inhibitor pre-treatment in NST-ACS using data from the Chest Pain-MI Registry. The study examines how guideline changes have influenced clinical practice, revealing a decline in pre-treatment rates, significant practice variations, and no major differences in outcomes except for longer hospital stays in CABG patients. Watch the video or listen as a podcast here, then check out the JACC article: https://www.jacc.org/doi/10.1016/j.jacc.2024.09.1227

In this second entry in the JACC-Baran Japanese language series, JACC Executive Associate Editor Mitsuaki Sawano, MD, Shun Kohsaka, MD, FACC, and Yuichi Shimada, MD, MPH, speak on topics ranging from all things Super Bowl to Dr. Shimada's recently published JACC paper, Comprehensive Proteomic Profiling of Human Myocardium Reveals Signaling Pathways Dysregulated in Hypertrophic Cardiomyopathy.

In this recording introducing the Japanese-language series of videos, JACC Executive Associate Editor Mitsuaki Sawano, MD, speaks with Shun Kohsaka, MD, FACC, and Shingo Matsumoto, MD, on topics from the effect of US government funding cuts on Japanese researchers to an in-depth discussion of the FINE-ARTS trial published in JACC, "Initial Decline in Glomerular Filtration Rate with Finerenone in HFpEF and HFmrEF: A Pre-Specified Analysis of FINEARTS-HF".

Send us a textWhat if the revolutions that shaped our world were never meant to begin in the most advanced nations? Join VarnVlog and Regrettable Century as we unravel the intricate tapestry of revolutionary decadence and world systems theory, exploring the profound insights of Samir Amin, Giovanni Arrighi, and Emmanuel Wallerstein. We embark on a journey through Amin's critical examination of Eurocentrism and his bold stance during the Egyptian revolution, where his support for the liberal side against Islamists served as a testament to his unique ideological position. Through probing discussions, we challenge traditional Marxist narratives and uncover the complexities of proletarian stratification and imperialism's ever-evolving definitions.This episode takes a deep dive into Marx's legacy, examining capitalism not just as a mode of production, but as a force that redefines societal structures. We tackle Marx's political integration into economic theories, appreciating Engels' contributions to anthropology and ecology, while offering a critical analysis of Baran and Sweezy's monopoly capital theory. Our conversation underscores capitalism's transient nature, urging a reconsideration of historical expectations and the need for theoretical adaptations to contemporary realities.From the mid-20th-century socialist revolutions to the rise of neoliberal economic restructuring, we map the shifting ideologies from Marxism to Islamism and the repercussions on global political landscapes. This episode critiques the evolution of developmentalist regimes and the reinterpretations of Lenin's theories, drawing parallels between the fall of ancient empires and modern capitalist crises. As we navigate these historical transitions and systemic oppressions, we invite you to question established paradigms and engage with the ever-changing narrative of global political ideologies. Musis by Bitterlake, Used with Permission, all rights to BitterlakeSupport the showCrew:Host: C. Derick VarnIntro and Outro Music by Bitter Lake.Intro Video Design: Jason MylesArt Design: Corn and C. Derick VarnLinks and Social Media:twitter: @varnvlogblue sky: @varnvlog.bsky.socialYou can find the additional streams on YoutubeCurrent Patreon at the Sponsor Tier: Jordan Sheldon, Mark J. Matthews, Lindsay Kimbrough, RedWolf

Episode 212 of The Business Development Podcast features a conversation with Sophie Baran, a rising leader in real estate development and private equity. As the General Partner and CEO of Bear Capital, Sophie has managed over $250 million in capital expenditures, playing a pivotal role in shaping Alberta's land development landscape. She shares her insider knowledge on transforming raw land into thriving communities, the challenges of raising capital, and why Western Canada is a prime market for real estate investment. With a background in corporate finance and leadership, Sophie reveals how she leveraged her expertise to build a diversified investment model, balancing high-growth opportunities with strategic risk management.In this inspiring discussion, Kelly Kennedy and Sophie explore the mindset shifts required to scale in a competitive industry, the importance of resilience in entrepreneurship, and why she believes now is the time to invest in real estate. She also shares the personal turning point that led her to leave a high-level leadership role and bet on herself as an entrepreneur. Whether you're an investor, a business leader, or simply interested in how rising industry leaders make bold moves, this episode delivers valuable insights from one of real estate's most dynamic emerging voices.Key Takeaways:1. Believing in yourself is the foundation for taking bold steps in business and entrepreneurship. 2. Hard economic times create opportunities for those who are resilient and willing to adapt. 3. Diversifying revenue streams reduces risk and builds long-term business stability. 4. Raising capital successfully depends on credibility, trust, and a clear value proposition. 5. The best markets for investment are often the ones that others overlook or hesitate to enter. 6. Strategic partnerships, including Indigenous collaborations, can create both financial success and lasting community impact. 7. Waiting for the perfect moment often leads to missed opportunities—taking action is what matters most. 8. Leadership requires making tough decisions and stepping outside of comfort zones. 9. Big ideas only succeed when paired with strong execution, planning, and financial discipline. 10. The greatest obstacles in business are often self-imposed—removing doubt and taking the first step is the key to success.Links referenced in this episode:capitalbd.cabarecapital.comCompanies mentioned in this episode: Bare Capital Landrex Capital Business Development Enbridge Canadian Western Bank TAG Developments Master Business Development with Kelly Kennedy – Book Your Free Discovery Session Business growth isn't about luck—it's about mastery. The Business Development Mastery Program with Kelly Kennedy gives you the tools, strategies, and confidence to scale your business, close more deals, and build lasting success. ✔ Proven business development frameworks that drive real results ✔ Personalized coaching tailored to your goals and challenges ✔ Actionable strategies to generate leads, close deals, and grow revenue If you're serious about taking your business development skills to the next level, let's talk. Book your free discovery session today and see how this program can help you achieve your goals. Book a Free Discovery Call

Madeleine Baran and Parker Yesko, investigative reporters with the New Yorker's In the Dark podcast, join Lawfare Managing Editor Tyler McBrien to discuss In the Dark: Season 3, which tells the story of a small group of Marines who killed 24 civilians in Haditha, Iraq, on Nov. 19, 2005.They also discussed “The War Crimes That the Military Buried,” a new database of possible American war crimes committed in Iraq and Afghanistan, which Baran and Yesko compiled over the course of their four-year investigation. To receive ad-free podcasts, become a Lawfare Material Supporter at www.patreon.com/lawfare. You can also support Lawfare by making a one-time donation at https://givebutter.com/c/trumptrials.Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

Baran, originally from Turkey, has lived in the U.S. for 23 years. With a background in engineering and over a decade of experience in car manufacturing, Baran transitioned into entrepreneurship in 2014, starting businesses in retail. For the past five years, he has been actively investing in real estate. After attending Rod's Bootcamp and becoming a Warrior, Baran has been involved in 12 units and has partnered with other Warriors to secure deals, collaborating on multiple projects.   Here's some of the topics we covered:   From Immigrant Dream to Real Estate Success How Baran Closed on a 12-Unit Multifamily Property in Knoxville Baran's Key Role in Making the Knoxville Deal Happen Where This Knoxville Property Is Headed and What's Next CapEx Demystified Game-Changing Impact of Cost Segregation in Multifamily Real Estate Expert Tips Every Real Estate Beginner Needs to Know Leveling Up To Bigger Deals   If you'd like to apply to the warrior program and do deals with other rockstars in this business: Text crush to 72345 and we'll be speaking soon. For more about Rod and his real estate investing journey go to www.rodkhleif.com

When we last listened to season three of “In the Dark,” Madeleine Baran had collected signatures from the families of the Haditha victims, hoping to obtain secret photographs of the massacre. In the final episodes of the season, the team gives the pictures to an analyst who says the images are clear evidence of a war crime. Military prosecutors eventually charged eight Marines for killing two dozen unarmed Iraqi men, women and children. But a cascade of immunity offers, intervention by commanding officers, and a generous plea bargain meant no one was held accountable for the murders in any meaningful way.The final episodes of “In the Dark” season three probes what went wrong with the prosecution of the infantrymen who rounded up and slaughtered civilians in retaliation for an IED attack. And while the number of victims in Haditha have been listed as 24, Baran and her team find evidence the number is too low.OUR SPOILER-FREE REVIEWS OF "IN THE DARK" EPISODES 6 THROUGH 9 BEGIN IN THE FINAL 11 MINUTES OF THE EPISODE. Donate to Kevin's Walk-a-Mile: ERAS fundraiser for the Crisis Center of Ctr NH.For exclusive podcasts and more, sign up at Patreon.Sign up for our newsletter at crimewriterson.com.